1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ASTRAZENECA PLC - ADR
Astrazeneca plc - ADR XNAS: AZN

Astrazeneca plc - ADR Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and m...

Read More
76.59 2.61 (3.53%)
25.07% Gain from 52W Low
10.3M
XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Mid Valuation
30.7 / 100
Momentum Score
Technically Moderately Bullish
64.0 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
86
1Yr Price target upside is 12%
11 analysts

17

S

4

W

1

O

2

T

SWOT Analysis

Astrazeneca plc - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..